pramipexole has been researched along with rasagiline in 15 studies
| Studies (pramipexole) | Trials (pramipexole) | Recent Studies (post-2010) (pramipexole) | Studies (rasagiline) | Trials (rasagiline) | Recent Studies (post-2010) (rasagiline) |
|---|---|---|---|---|---|
| 1,103 | 219 | 517 | 535 | 72 | 314 |
| Protein | Taxonomy | pramipexole (IC50) | rasagiline (IC50) |
|---|---|---|---|
| Cholinesterase | Homo sapiens (human) | 2.3865 | |
| Amine oxidase [flavin-containing] B | Rattus norvegicus (Norway rat) | 1.0029 | |
| Amine oxidase [flavin-containing] A | Rattus norvegicus (Norway rat) | 0.2115 | |
| Amine oxidase [flavin-containing] A | Homo sapiens (human) | 1.088 | |
| Acetylcholinesterase | Homo sapiens (human) | 0.019 | |
| Amine oxidase [flavin-containing] B | Homo sapiens (human) | 0.2217 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (20.00) | 29.6817 |
| 2010's | 10 (66.67) | 24.3611 |
| 2020's | 2 (13.33) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Goetz, CG; Poewe, W; Rascol, O; Sampaio, C | 1 |
| Schapira, AH | 1 |
| Armand, C; Cochran, J; François, C; Haycox, A; Murteira, S | 1 |
| Bozi, M; Christodoulou, C; Douzenis, A; Gasparinatos, G; Stamboulis, E; Stefanis, C; Stefanis, L; Stefanis, N | 1 |
| Janszky, J; Kovacs, N; Nagy, F | 1 |
| Arami, MA; Ayromlou, H; Najmi, S | 1 |
| Tarrants, ML; Zagmutt, FJ | 1 |
| Blin, O; Lancrenon, S; Pitel, S; Viallet, F | 1 |
| Sheehan, J; Thorpe, M; Wilson, L | 1 |
| Agúndez, JA; Alonso-Navarro, H; García-Martín, E; Jiménez-Jiménez, FJ | 1 |
| Elmer, L; Friedman, H; Giladi, N; Hauser, RA; Kadosh, S; Kieburtz, K; Klepiskaya, OS; Kreitzman, DL; Leinonen, M; Lew, MF; Linvah, N; Litman, P; Olanow, CW; Russell, DS; The P B Study Group, F | 1 |
| Challet-Bouju, G; Derkinderen, P; Fève, JM; Grall-Bronnec, M; Le Moigne, M; Leboucher, J; Victorri-Vigneau, C | 1 |
| Kalaria, D; Kalia, YN; Serna, C; Singhal, M | 1 |
| Brotchie, J; Friedman, H; Giladi, N; Hauser, RA; Litman, P; Oren, S; Poewe, W | 1 |
6 review(s) available for pramipexole and rasagiline
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Evidence-based medical review update: pharmacological and surgical treatments of Parkinson's disease: 2001 to 2004.
Topics: Amantadine; Antiparkinson Agents; Apomorphine; Benzophenones; Benzothiazoles; Bromocriptine; Cabergoline; Catechol O-Methyltransferase Inhibitors; Deep Brain Stimulation; Dihydroergocryptine; Ergolines; Fetal Tissue Transplantation; Globus Pallidus; Humans; Indans; Indoles; Levodopa; Lisuride; Mesencephalon; Monoamine Oxidase Inhibitors; Neurosurgical Procedures; Nitrophenols; Parkinson Disease; Pergolide; Piribedil; Pramipexole; Selegiline; Thiazoles; Tolcapone | 2005 |
Present and future drug treatment for Parkinson's disease.
Topics: Benzothiazoles; Corpus Striatum; Disease Progression; Dopamine Agonists; Drug Therapy, Combination; Humans; Indans; Indoles; Levodopa; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Parkinson Disease; Pramipexole; Psychomotor Performance; Sexual Dysfunction, Physiological; Sleep Wake Disorders; Substantia Nigra; Thiazoles; Urinary Incontinence | 2005 |
Indirect comparisons of adverse events and dropout rates in early Parkinson's disease trials of pramipexole, ropinirole, and rasagiline.
Topics: Antiparkinson Agents; Benzothiazoles; Cognition Disorders; Cross-Sectional Studies; Databases, Bibliographic; Fatigue; Female; Gastrointestinal Diseases; Humans; Indans; Indoles; Logistic Models; Male; Parkinson Disease; Patient Dropouts; Pramipexole; Sleep Wake Disorders; Treatment Outcome | 2012 |
Anti-Parkinson's disease drugs and pharmacogenetic considerations.
Topics: Aryl Hydrocarbon Hydroxylases; Benzothiazoles; Benztropine; Bromocriptine; Cabergoline; Catechols; Cytochrome P-450 CYP1A2; Cytochrome P-450 CYP1A2 Inhibitors; Cytochrome P-450 CYP2B6; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP3A; Ergolines; Genetic Markers; Humans; Indans; Indoles; Levodopa; Lisuride; Nitriles; Parkinson Disease; Pergolide; Pharmacogenetics; Pramipexole; Receptors, Dopamine D2; Receptors, Dopamine D3; Reproducibility of Results; Selegiline | 2013 |
P2B001 (Extended Release Pramipexole and Rasagiline): A New Treatment Option in Development for Parkinson's Disease.
Topics: Humans; Indans; Levodopa; Parkinson Disease; Pramipexole | 2022 |
2 trial(s) available for pramipexole and rasagiline
| Article | Year |
|---|---|
Evaluation of the safety and tolerability of rasagiline in the treatment of the early stages of Parkinson's disease.
Topics: Aged; Antiparkinson Agents; Benzothiazoles; Double-Blind Method; Female; Gastrointestinal Diseases; Humans; Indans; Male; Middle Aged; Monoamine Oxidase Inhibitors; Parkinson Disease; Pramipexole; Sleep Wake Disorders; Time Factors | 2013 |
A randomized trial of a low-dose Rasagiline and Pramipexole combination (P2B001) in early Parkinson's disease.
Topics: Aged; Antiparkinson Agents; Benzothiazoles; Delayed-Action Preparations; Double-Blind Method; Drug Combinations; Female; Humans; Indans; Israel; Male; Middle Aged; Neuroprotective Agents; Parkinson Disease; Pramipexole; Severity of Illness Index; Triethylenemelamine; United States | 2017 |
7 other study(ies) available for pramipexole and rasagiline
| Article | Year |
|---|---|
Cost effectiveness of rasagiline and pramipexole as treatment strategies in early Parkinson's disease in the UK setting: an economic Markov model evaluation.
Topics: Aged; Antiparkinson Agents; Benzothiazoles; Clinical Trials as Topic; Cost-Benefit Analysis; Disease Progression; Dopamine Agonists; Female; Health Care Costs; Humans; Indans; Insurance, Health, Reimbursement; Male; Markov Chains; Middle Aged; Models, Economic; Monoamine Oxidase Inhibitors; Monte Carlo Method; Parkinson Disease; Pramipexole; Probability; Quality-Adjusted Life Years; State Medicine; Treatment Outcome; United Kingdom | 2009 |
Isolated delusional syndrome in Parkinson's Disease.
Topics: Aged; Amantadine; Antiparkinson Agents; Benserazide; Benzothiazoles; Catechols; Clonazepam; Female; Humans; Indans; Indoles; Levodopa; Male; Middle Aged; Nitriles; Parkinson Disease; Pramipexole; Schizophrenia, Paranoid; Syndrome | 2010 |
Cost effectiveness of rasagiline and pramipexole as treatment strategies in early Parkinson's disease in the UK setting: An economic Markov model evaluation.
Topics: Aged; Antiparkinson Agents; Benzothiazoles; Cost-Benefit Analysis; Dopamine Agonists; Humans; Indans; Markov Chains; Models, Economic; Monoamine Oxidase Inhibitors; Parkinson Disease; Pramipexole; United Kingdom | 2011 |
Hemiparkinsonism-hemiatrophy syndrome.
Topics: Adult; Antiparkinson Agents; Atrophy; Benzothiazoles; Biperiden; Carbidopa; Cerebral Cortex; Cerebral Ventricles; Dopamine Agonists; Drug Combinations; Humans; Indans; Levodopa; Magnetic Resonance Imaging; Male; Monoamine Oxidase Inhibitors; Parkinson Disease, Secondary; Pramipexole; Tomography, X-Ray Computed | 2011 |
Three cases of impulse control disorder in Parkinson's disease patients receiving dopamine replacement therapy.
Topics: Adult; Amantadine; Antiparkinson Agents; Benzothiazoles; Carbidopa; Catechols; Disruptive, Impulse Control, and Conduct Disorders; Drug Combinations; Female; Humans; Indans; Indoles; Levodopa; Male; Middle Aged; Neuroprotective Agents; Parkinson Disease; Pramipexole; Selegiline | 2013 |
Hair-pulling disorder complicated by skin-picking disorder: An unknown side-effect of dopamine replacement therapy?
Topics: Benzothiazoles; Dopamine Agonists; Drug Therapy, Combination; Female; Humans; Indans; Indoles; Middle Aged; Monoamine Oxidase Inhibitors; Pramipexole; Self-Injurious Behavior; Trichotillomania | 2018 |
Effect of continuous and multi-phasic current profiles on the iontophoretic transport of pramipexole, rasagiline and huperzine A: Depicting temporal variation and biodistribution in the skin.
Topics: Administration, Cutaneous; Alkaloids; Indans; Iontophoresis; Pramipexole; Sesquiterpenes; Skin; Tissue Distribution | 2021 |